Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
January-2021 Volume 23 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2021 Volume 23 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Ginsenoside Rg1 improves pathological damages by activating the p21‑p53‑STK pathway in ovary and Bax‑Bcl2 in the uterus in premature ovarian insufficiency mouse models

  • Authors:
    • Lianli He
    • Xiaojuan Wang
    • Daigang Cheng
    • Zhengai Xiong
    • Xiaoyun Liu
  • View Affiliations / Copyright

    Affiliations: Department of Gynecology and Obstetrics, The First People's Hospital of Zunyi and Third Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China, Department of Gynecology and Obstetrics, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, P.R. China
    Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 37
    |
    Published online on: November 10, 2020
       https://doi.org/10.3892/mmr.2020.11675
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to investigate the effects of the ginsenoside Rg1 on D‑galactose (D‑gal)‑induced mouse models of premature ovarian insufficiency (POI) and the related mechanisms. C57BL/6 female mice were randomly grouped into the following: i) D‑gal [subcutaneously (s.c.) 200 mg/kg/d D‑gal for 42 days]; ii) Rg1 [intraperitoneally (i.p.) 20 mg/kg/d Rg1 for 28 days]; iii) D‑gal + Rg1 (s.c. 200 mg/kg/d D‑gal for 42 days followed by i.p. 20 mg/kg/d Rg1 for 28 days); and iv) saline groups (equivalent volume of saline s.c. and i.p.). Hematoxylin and eosin staining and electron microscopy were used to analyze uterine and ovarian morphology. Expression levels of senescence factors (p21, p53 and serine/threonine kinase), secretion of pro‑inflammatory cytokines [interleukin (IL)‑6, tumor necrosis factor (TNF)‑α and IL‑1β] and the activities of oxidation biomarkers [superoxide dismutase (T‑SOD), malondialdehyde (MDA) and glutathione peroxidase (GSH‑px)] were analyzed. The results showed that mice in the Rg1 + D‑gal group had significantly higher uterine and ovarian weight compared with those in the D‑gal group. Uterus morphology was also improved, based on the comparison between the D‑gal group and the Rg1 + D‑gal group. In addition, the Rg1 treatment after D‑gal administration significantly decreased the expression of senescence‑associated factors, enhanced the activities of anti‑oxidant enzymes total T‑SOD and GSH‑px in addition to reducing TNF‑α, IL‑1β, MDA and IL‑6 (based on the comparison between the D‑gal group and the Rg1 + D‑gal group). In conclusion, the present study suggested that the ginsenoside Rg1 improved pathological damages in the ovary and uterus by increasing anti‑oxidant and anti‑inflammatory abilities whilst reducing the expression of senescence signaling pathways in POI mouse models.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Rossetti R, Ferrari I, Bonomi M and Persani L: Genetics of primary ovarian insufficiency. Clin Genet. 91:183–198. 2017. View Article : Google Scholar : PubMed/NCBI

2 

Laven JS: Primary ovarian insufficiency. Semin Reprod Med. 34:230–234. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Qin C, Chen Y, Lin Q, Yao J, Wu W and Xie J: The significance of polymorphism and expression of oestrogen metabolism-related genes in Chinese women with premature ovarian insufficiency. Reprod Biomed Online. 35:609–615. 2017. View Article : Google Scholar : PubMed/NCBI

4 

Huang Y, Hu C, Ye H, Luo R, Fu X, Li X, Huang J, Chen W and Zheng Y: Inflamm-aging: A new mechanism affecting premature ovarian insufficiency. J Immunol Res. 2019:80698982019. View Article : Google Scholar : PubMed/NCBI

5 

European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI, ; Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B, Cifkova R, de Muinck Keizer-Schrama S, Hogervorst E, et al: ESHRE guideline: Management of women with premature ovarian insufficiency. Hum Reprod. 31:926–937. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Soman M, Huang LC, Cai WH, Xu JB, Chen JY, He RK, Ruan HC, Xu XR, Qian ZD and Zhu XM: Serum androgen profiles in women with premature ovarian insufficiency: A systematic review and meta-analysis. Menopause. 26:78–93. 2019. View Article : Google Scholar : PubMed/NCBI

7 

Vujović S, Ivovic M, Tančić-Gajić M, Marina L, Ljubic A, Dragojević-Dikić S and Genazzani AR: Endometrium receptivity in premature ovarian insufficiency-how to improve fertility rate and predict diseases? Gynecol Endocrinol. 34:1011–1015. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Patel H, Arruarana V, Yao L, Cui X and Ray E: Effects of hormones and hormone therapy on breast tissue in transgender patients: A concise review. Endocrine. 68:6–15. 2020. View Article : Google Scholar : PubMed/NCBI

9 

Zhu C, Wang Y, Liu H, Mu H, Lu Y, Zhang J and Huang J: Oral administration of Ginsenoside Rg1 prevents cardiac toxicity induced by doxorubicin in mice through anti-apoptosis. Oncotarget. 8:83792–83801. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Zhu J, Mu X, Zeng J, Xu C, Liu J, Zhang M, Li C, Chen J, Li T and Wang Y: Ginsenoside Rg1 prevents cognitive impairment and hippocampus senescence in a rat model of D-galactose-induced aging. PLoS One. 9:e1012912014. View Article : Google Scholar : PubMed/NCBI

11 

Yang N, Zhou B, Wang Y, Li Y, Liu J, Li P, Yang N, Zhou B, Wang Y, et al: Research progress of the biological activity of the ginsenoside Rg. Chinese J Traditional Chinese Med. 33:1463–1465. 2018.(In Chinese).

12 

Tang F, Lu M, Yu L, Wang Q, Mei M, Xu C, Han R, Hu J, Wang H and Zhang Y: Inhibition of TNF-α-mediated NF-κB activation by ginsenoside Rg1 contributes the attenuation of cardiac hypertrophy induced by abdominal aorta coarctation. J Cardiovasc Pharmacol. 68:257–264. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Lee HY, Park SH, Chae SW, Soung NK, Oh MJ, Kim JS, Kim YO and Chae HJ: Aqueous ginseng extract has a preventive role in RANKL-induced osteoclast differentiation and estrogen deficiency-induced osteoporosis. J Functional Foods. 13:192–203. 2015. View Article : Google Scholar

14 

Cui Y, Shu XO, Gao YT, Cai H, Tao MH and Zheng W: Association of ginseng use with survival and quality of life among breast cancer patients. Am J Epidemiol. 163:645–653. 2006. View Article : Google Scholar : PubMed/NCBI

15 

Ryan J, Scali J, Carriere I, Ritchie K and Ancelin ML: Hormonal treatment, mild cognitive impairment and Alzheimer's disease. Int Psychogeriatr. 20:47–56. 2008. View Article : Google Scholar : PubMed/NCBI

16 

Zhao E and Mu Q: Phytoestrogen biological actions on Mammalian reproductive system and cancer growth. Sci Pharm. 79:1–20. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Cheng Y, Shen LH and Zhang JT: Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol Sin. 26:143–149. 2005. View Article : Google Scholar : PubMed/NCBI

18 

Li J, Cai D, Yao X, Zhang Y, Chen L, Jing P, Wang L and Wang Y: Protective effect of ginsenoside Rg1 on hematopoietic stem/progenitor cells through attenuating oxidative stress and the Wnt/β-Catenin signaling pathway in a mouse model of d-Galactose-induced aging. Int J Mol Sci. 17:8492016. View Article : Google Scholar

19 

He L: Establishment of D-gal induced premature ovarian failure animal model. Proc Clin Med. 25:762–764. 2016.(In Chinese).

20 

Huang JL, Yu C, Su M, Yang SM, Zhang F, Chen YY, Liu JY, Jiang YF, Zhong ZG, et al: Probucol, a “non-statin” cholesterol-lowering drug, ameliorates D-galactose induced cognitive deficits by alleviating oxidative stress via Keap1/Nrf2 signaling pathway in mice. Aging (Albany NY). 11:8542–8555. 2019. View Article : Google Scholar : PubMed/NCBI

21 

Thakur M, Shaeib F, Khan SN, Kohan-Ghadr HR, Jeelani R, Aldhaheri SR, Gonik B and Abu-Soud HM: Galactose and its metabolites deteriorate metaphase II mouse oocyte quality and subsequent embryo development by disrupting the spindle structure. Sci Rep. 7:2312017. View Article : Google Scholar : PubMed/NCBI

22 

Banerjee S, Chakraborty P, Saha P, Bandyopadhyay SA, Banerjee S and Kabir SN: Ovotoxic effects of galactose involve attenuation of follicle-stimulating hormone bioactivity and up-regulation of granulosa cell p53 expression. PLoS One. 7:e307092012. View Article : Google Scholar : PubMed/NCBI

23 

Sozen B, Ozekinci M, Erman M, Gunduz T, Demir N and Akouri R: Dehydroepiandrosterone supplementation attenuates ovarian ageing in a galactose-induced primary ovarian insufficiency rat model. J Assist Reprod Genet. 36:2181–2189. 2019. View Article : Google Scholar : PubMed/NCBI

24 

Kim EM, Jung CH, Kim J, Hwang SG, Park JK and Um HD: The p53/p21 complex regulates cancer cell invasion and apoptosis by targeting Bcl-2 family proteins. Cancer Res. 77:3092–3100. 2017. View Article : Google Scholar : PubMed/NCBI

25 

Zińczuk J, Zaręba K, Guzińska-Ustymowicz K, Kędra B, Kemona A and Pryczynicz A: p16, p21, and p53 proteins play an important role in development of pancreatic intraepithelial neoplastic. Ir J Med Sci. 187:629–637. 2018. View Article : Google Scholar : PubMed/NCBI

26 

Ibnat N, Kamaruzman NI, Ashaie M and Chowdhury EH: Transfection with p21 and p53 tumor suppressor plasmids suppressed breast tumor growth in syngeneic mouse model. Gene. 701:32–40. 2019. View Article : Google Scholar : PubMed/NCBI

27 

Fujino T, Yokokawa R, Oshima T and Hayakawa M: SIRT1 knockdown up-regulates p53 and p21/Cip1 expression in renal adenocarcinoma cells but not in normal renal-derived cells in a deacetylase-independent manner. J Toxicol Sci. 43:711–715. 2018. View Article : Google Scholar : PubMed/NCBI

28 

Dmitrieva AI, Serebryakova VA, Rakitin SS, Kudyakov LA, Novitskii VV, Yankovich KI and Sevostyanova NV: Study of the association of polymorphisms of p53 and p21 with the risk of development of stomach cancer. Bull Exp Biol Med. 164:95–98. 2017. View Article : Google Scholar : PubMed/NCBI

29 

Ramadan MA, Shawkey AE, Rabeh MA and Abdellatif AO: Expression of P53, BAX, and BCL-2 in human malignant melanoma and squamous cell carcinoma cells after tea tree oil treatment in vitro. Cytotechnology. 71:461–473. 2019. View Article : Google Scholar : PubMed/NCBI

30 

Cicero L, Fazzotta S, Palumbo VD, Cassata G and Lo Monte AI: Anesthesia protocols in laboratory animals used for scientific purposes. Acta Biomed. 89:337–342. 2018.PubMed/NCBI

31 

Boivin GP, Bottomley MA, Schiml PA, Goss L and Grobe N: Physiologic, behavioral, and histologic responses to various euthanasia methods in C57BL/6NTac male mice. J Am Assoc Lab Anim Sci. 56:69–78. 2017.PubMed/NCBI

32 

Wang Q, Yin J, Wang S, Cui D, Lin H, Ge M, Dai Z, Xie L, Si J, Ma K, et al: Effects of activin A and its downstream ERK1/2 in oxygen and glucose deprivation after isoflurane-induced postconditioning. Biomed Pharmacother. 84:535–543. 2016. View Article : Google Scholar : PubMed/NCBI

33 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

34 

Saat N, Risvanli A, Dogan H, Onalan E, Akpolat N, Seker I and Sahna E: Effect of melatonin on torsion and reperfusion induced pathogenesis of rat uterus. Biotech Histochem. 94:533–539. 2019. View Article : Google Scholar : PubMed/NCBI

35 

Chen MJ, Chou CH, Shun CT, Mao TL, Wen WF, Chen CD, Chen SU, Yang YS and Ho HN: Iron suppresses ovarian granulosa cell proliferation and arrests cell cycle through regulating p38 mitogen-activated protein kinase/p53/p21 pathway. Biol Reprod. 97:438–448. 2017. View Article : Google Scholar : PubMed/NCBI

36 

da Costa JP, Vitorino R, Silva GM, Vogel C, Duarte AC and Rocha-Santos T: A synopsis on aging-theories, mechanisms and future prospects. Ageing Res Rev. 29:90–112. 2016. View Article : Google Scholar : PubMed/NCBI

37 

Flatt T and Partridge L: Horizons in the evolution of aging. BMC Biol. 16:932018. View Article : Google Scholar : PubMed/NCBI

38 

Sun C, Fan S, Wang X, Lu J, Zhang Z, Wu D, Shan Q and Zheng Y: Purple sweet potato color inhibits endothelial premature senescence by blocking the NLRP3 inflammasome. J Nutr Biochem. 26:1029–1040. 2015. View Article : Google Scholar : PubMed/NCBI

39 

Sullivan SD, Sarrel PM and Nelson LM: Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril. 106:1588–1599. 2016. View Article : Google Scholar : PubMed/NCBI

40 

Riegle van West K, Stinear C and Buck R: The effects of poi on physical and cognitive function in healthy older adults. J Aging Phys Act. Nov 8–2018.(Online ahead of print). PubMed/NCBI

41 

Sundaresan NR, Saxena VK, Sastry KV, Nagarajan K, Jain P, Singh R, Anish D, Ravindra PV, Saxena M and Ahmed KA: Cytokines and chemokines in postovulatory follicle regression of domestic chicken (Gallus gallus domesticus). Dev Comp Immunol. 32:253–264. 2008. View Article : Google Scholar : PubMed/NCBI

42 

He L, Ling L, Wei T, Wang Y and Xiong Z: Ginsenoside Rg1 improves fertility and reduces ovarian pathological damages in premature ovarian failure model of mice. Exp Biol Med (Maywood). 242:683–691. 2017. View Article : Google Scholar : PubMed/NCBI

43 

Mou Z, Huang Q, Chu SF, Zhang MJ, Hu JF, Chen NH and Zhang JT: Antidepressive effects of ginsenoside Rg1 via regulation of HPA and HPG axis. Biomed Pharmacother. 92:962–971. 2017. View Article : Google Scholar : PubMed/NCBI

44 

Mo J, Zhou Y, Yang R, Zhang P, He B, Yang J, Li S, Shen Z and Chen P: Ginsenoside Rg1 ameliorates palmitic acid-induced insulin resistance in HepG2 cells in association with modulating Akt and JNK activity. Pharmacol Rep. 71:1160–1167. 2019. View Article : Google Scholar : PubMed/NCBI

45 

Yan Z, Dai Y, Fu H, Zheng Y, Bao D, Yin Y, Chen Q, Nie X, Hao Q, Hou D and Cui Y: Curcumin exerts a protective effect against premature ovarian failure in mice. J Mol Endocrinol. 60:261–271. 2018. View Article : Google Scholar : PubMed/NCBI

46 

Mullen RD, Ontiveros AE, Moses MM and Behringer RR: AMH and AMHR2 mutations: A spectrum of reproductive phenotypes across vertebrate species. Dev Biol. 455:1–9. 2019. View Article : Google Scholar : PubMed/NCBI

47 

Roness H and Meirow D: Fertility preservation: Follicle reserve loss in ovarian tissue transplantation. Reproduction. 158:F35–F44. 2019. View Article : Google Scholar : PubMed/NCBI

48 

Warren L, Murawski M, Wilk K, Zieba DA and Bartlewski PM: Suitability of antral follicle counts and computer-assisted analysis of ultrasonographic and magnetic resonance images for estimating follicular reserve in porcine, ovine and bovine ovaries ex situ. Exp Biol Med (Maywood). 240:576–584. 2015. View Article : Google Scholar : PubMed/NCBI

49 

Song D, Zhong Y, Qian C, Zou Q, Ou J, Shi Y, Gao L, Wang G, Liu Z, Li H, et al: Human umbilical cord mesenchymal stem cells therapy in cyclophosphamide-induced premature ovarian failure rat model. Biomed Res Int. 2016:25175142016. View Article : Google Scholar : PubMed/NCBI

50 

Liu Y, Li YJ and Wang L: Changes of expression of p53-p21 in premature ovarian failure in fluorosis female mice. Chongqing Med. 13:1712–1715. 2018.

51 

Podfigurna-Stopa A, Czyzyk A, Grymowicz M, Smolarczyk R, Katulski K, Czajkowski K and Meczekalski B: Premature ovarian insufficiency: The context of long-term effects. J Endocrinol Invest. 39:983–990. 2016. View Article : Google Scholar : PubMed/NCBI

52 

He L: Preliminary study on animal model of ovarian premature failure induced by d-galactose. Clin Med Practice. 10:762–764. 2016.

53 

Ali DE, Shah M, Ali A, Malik MO, Rehman F, Badshah H, Ehtesham E and Vitale SG: Treatment with metformin and combination of metformin plus pioglitazone on serum levels of IL-6 and IL-8 in polycystic ovary syndrome: A randomized clinical trial. Horm Metab Res. 51:714–722. 2019. View Article : Google Scholar : PubMed/NCBI

54 

Qin C, Yuan Z, Yao J, Zhu W, Wu W and Xie J: AMH and AMHR2 genetic variants in Chinese women with primary ovarian insufficiency and normal age at natural menopause. Reprod Biomed Online. 3:311–318. 2014. View Article : Google Scholar

55 

Thakur M, Feldman G and Puscheck EE: Primary ovarian insufficiency in classic galactosemia: Current understanding and future research opportunities. J Assist Reprod Genet. 35:3–16. 2018. View Article : Google Scholar : PubMed/NCBI

56 

Wang W, Wang Y, Wu J, Yang L and Liu Z: Protective effects of electroacupuncture pretreatment on ovarian in rats with premature ovarian insufficiency. Zhongguo Zhen Jiu. 38:405–411. 2018.(In Chinese). PubMed/NCBI

57 

Yuan S, Wen J, Cheng J, Shen W, Zhou S, Yan W, Shen L, Luo A and Wang S: Age-associated up-regulation of EGR1 promotes granulosa cell apoptosis during follicle atresia in mice through the NF-κB pathway. Cell Cycle. 15:2895–2905. 2016. View Article : Google Scholar : PubMed/NCBI

58 

Yang F, Pei R, Zhang Z, Liao J, Yu W, Qiao N, Han Q, Li Y, Hu L, Guo J, et al: Copper induces oxidative stress and apoptosis through mitochondria-mediated pathway in chicken hepatocytes. Toxicol In Vitro. 54:310–316. 2019. View Article : Google Scholar : PubMed/NCBI

59 

Falfushynska HI, Gnatyshyna LL, Deneha HV, Osadchuk OY and Stoliar OB: Manifestations of oxidative stress and molecular damages in ovarian cancer tissue. Ukr Biochem J. 87:93–102. 2015. View Article : Google Scholar : PubMed/NCBI

60 

Zhang L, Kong XJ, Wang ZQ, Xu FS and Zhu YT: A study on neuroprotective effects of curcumin on the diabetic rat brain. J Nutr Health Aging. 20:835–840. 2016. View Article : Google Scholar : PubMed/NCBI

61 

Biswas P, Mukhopadhyay A, Kabir SN and Mukhopadhyay PK: High-protein diet ameliorates arsenic-induced oxidative stress and antagonizes uterine apoptosis in rats. Biol Trace Elem Res. 192:222–233. 2019. View Article : Google Scholar : PubMed/NCBI

62 

Xie W, Zhou P, Sun Y, Meng X, Dai Z, Sun G and Sun X: Protective effects and target network analysis of ginsenoside Rg1 in cerebral ischemia and reperfusion injury: A comprehensive overview of experimental studies. Cells. 7:2702018. View Article : Google Scholar

63 

Fan C, Song Q, Wang P, Li Y, Yang M and Yu SY: Neuroprotective effects of ginsenoside-Rg1 against depression-like behaviors via suppressing glial activation, synaptic deficits, and neuronal apoptosis in rats. Front Immunol. 9:28892018. View Article : Google Scholar : PubMed/NCBI

64 

Yang MZ, Li SG, et al: Effect of ginsenosideRg3 on ageing of vascular smooth muscle cells and itsm echanism. Heart BrainVessel Dis. 17:1079–1082. 2015.

65 

Chen M, Zhang H, Zhang G, Zhong A, Ma Q, Kai J, Tong Y, Xie S, Wang Y, Zheng H, et al: Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer. Biochem Biophys Res Commun. 507:74–82. 2018. View Article : Google Scholar : PubMed/NCBI

66 

Uxa S, Bernhart SH, Mages CFS, Fischer M, Kohler R, Hoffmann S, Stadler PF, Engeland K and Müller GA: DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation. Nucleic Acids Res. 47:9087–9103. 2019. View Article : Google Scholar : PubMed/NCBI

67 

Ma M, Chen XY, Li B and Li XT: Melatonin protects premature ovarian insufficiency induced by tripterygium glycosides: Role of SIRT1. Am J Transl Res. 9:1580–1602. 2017.PubMed/NCBI

68 

Hussein MR: Apoptosis in the ovary: Molecular mechanisms. Hum Reprod Update. 11:162–177. 2005. View Article : Google Scholar : PubMed/NCBI

69 

el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell. 75:817–825. 1993. View Article : Google Scholar : PubMed/NCBI

70 

Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:805–816. 1993. View Article : Google Scholar : PubMed/NCBI

71 

Hussein MR, Haemel AK and Wood GS: Apoptosis and melanoma: Molecular mechanisms. J Pathol. 199:275–288. 2003. View Article : Google Scholar : PubMed/NCBI

72 

Hormozi M, Ghoreishi S and Baharvand P: Astaxanthin induces apoptosis and increases activity of antioxidant enzymes in LS-180 cells. Artif Cells Nanomed Biotechnol. 47:891–895. 2019. View Article : Google Scholar : PubMed/NCBI

73 

Vartak SV, Iyer D, Santhoshkumar TR, Sharma S, Mishra A, Goldsmith G, Srivastava M, Srivastava S, Karki SS, Surolia A, et al: Novel BCL2 inhibitor, Disarib induces apoptosis by disruption of BCL2-BAK interaction. Biochem Pharmacol. 131:16–28. 2017. View Article : Google Scholar : PubMed/NCBI

74 

Rahmani M, Nkwocha J, Hawkins E, Pei X, Parker RE, Kmieciak M, Leverson JD, Sampath D, Ferreira-Gonzalez A and Grant S: Cotargeting BCL-2 and PI3K induces BAX-dependent mitochondrial apoptosis in AML cells. Cancer Res. 78:3075–3086. 2018. View Article : Google Scholar : PubMed/NCBI

75 

Mousa AM, Al-Fadhli AS, Rao MS and Kilarkaje N: Gestational lead exposure induces developmental abnormalities and up-regulates apoptosis of fetal cerebellar cells in rats. Drug Chem Toxicol. 38:73–83. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
He L, Wang X, Cheng D, Xiong Z and Liu X: Ginsenoside Rg1 improves pathological damages by activating the p21‑p53‑STK pathway in ovary and Bax‑Bcl2 in the uterus in premature ovarian insufficiency mouse models. Mol Med Rep 23: 37, 2021.
APA
He, L., Wang, X., Cheng, D., Xiong, Z., & Liu, X. (2021). Ginsenoside Rg1 improves pathological damages by activating the p21‑p53‑STK pathway in ovary and Bax‑Bcl2 in the uterus in premature ovarian insufficiency mouse models. Molecular Medicine Reports, 23, 37. https://doi.org/10.3892/mmr.2020.11675
MLA
He, L., Wang, X., Cheng, D., Xiong, Z., Liu, X."Ginsenoside Rg1 improves pathological damages by activating the p21‑p53‑STK pathway in ovary and Bax‑Bcl2 in the uterus in premature ovarian insufficiency mouse models". Molecular Medicine Reports 23.1 (2021): 37.
Chicago
He, L., Wang, X., Cheng, D., Xiong, Z., Liu, X."Ginsenoside Rg1 improves pathological damages by activating the p21‑p53‑STK pathway in ovary and Bax‑Bcl2 in the uterus in premature ovarian insufficiency mouse models". Molecular Medicine Reports 23, no. 1 (2021): 37. https://doi.org/10.3892/mmr.2020.11675
Copy and paste a formatted citation
x
Spandidos Publications style
He L, Wang X, Cheng D, Xiong Z and Liu X: Ginsenoside Rg1 improves pathological damages by activating the p21‑p53‑STK pathway in ovary and Bax‑Bcl2 in the uterus in premature ovarian insufficiency mouse models. Mol Med Rep 23: 37, 2021.
APA
He, L., Wang, X., Cheng, D., Xiong, Z., & Liu, X. (2021). Ginsenoside Rg1 improves pathological damages by activating the p21‑p53‑STK pathway in ovary and Bax‑Bcl2 in the uterus in premature ovarian insufficiency mouse models. Molecular Medicine Reports, 23, 37. https://doi.org/10.3892/mmr.2020.11675
MLA
He, L., Wang, X., Cheng, D., Xiong, Z., Liu, X."Ginsenoside Rg1 improves pathological damages by activating the p21‑p53‑STK pathway in ovary and Bax‑Bcl2 in the uterus in premature ovarian insufficiency mouse models". Molecular Medicine Reports 23.1 (2021): 37.
Chicago
He, L., Wang, X., Cheng, D., Xiong, Z., Liu, X."Ginsenoside Rg1 improves pathological damages by activating the p21‑p53‑STK pathway in ovary and Bax‑Bcl2 in the uterus in premature ovarian insufficiency mouse models". Molecular Medicine Reports 23, no. 1 (2021): 37. https://doi.org/10.3892/mmr.2020.11675
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team